|Articles|April 25, 2017
Schulman IRBs IBC Service to Launch in May
Schulman IRB announced its commercial institutional biosafety committee (IBC) service will launch in May 2017.
Advertisement
Schulman IRB announced its commercial institutional biosafety committee (IBC) service will launch in May 2017. The IBC service represents Schulman’s response to requests from research sponsors, CROs and institutions seeking an independent option for establishing IBCs when required by federal guidelines.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
2
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
3
AI-Driven Clinical Trial Recruitment and Design
4
What Clinical Trials Can Learn from the Gig Economy About Payments
5